XQuick Search
Safeair injection cabinet in the semi-sterile room: Safety profile and early results of new design intravitreal injection room with double security
Hakan Koc, Seda UzunogluDepartment of Ophthalmology, Giresun University Faculty of Medicine, Giresun, TürkiyePURPOSE: The purpose of the study was to determine the rate of endophthalmitis in intravitreal injection (IVI) cases performed in the IVI cabinet inside the semi-sterile room developed in accordance with the operating room conditions and to evaluate the results of the performance tests of the IVI cabinet.
METHODS: The number of IVIs, the type of drug administered intravitreally, ocular pathologies leading to IVI, possible endophthalmitis occurrence, and demographic characteristics of the patients were retrospectively analyzed between February 2023 and March 2024 in the IVI cabinet inside the semi-sterile IVI room in the Ophthalmology Department of Giresun Training and Research Hospital.
RESULTS: A total of 1082 patients were included in the study. A total of 4380 IVIs were performed. The drugs used in IVIs were Bevacizumab in 2776 (63.4%), Ranibizumab in 697 (15.9%), Aflibercept in 678 (15.5%), and Dexamethasone implant in 229 (5.2%). The indication diagnoses for IVI were diabetic macular edema in 573 (53%) patients, exudative age-related macular degeneration in 292 (27%) patients, retinal vascular occlusion in 163 (15%) patients, non-infectious uveitis in 39 (3.6%) patients, and myopic choroidal neovascularization in 15 (1.4%) patients. None (0%) of the IVIs administered to the patients in the IVI cabinet in a semi-sterile room developed endophthalmitis.
CONCLUSION: IVIs can be administered effectively and safely in the IVI cabinet system in a semi-sterile chamber.
Manuscript Language: English
